SHERRY AULIN - 03 Jun 2021 Form 3 Insider Report for Xenon Pharmaceuticals Inc. (XENE)

Role
Chief Financial Officer
Signature
/s/ Cassandra Robinson, Attorney-in-fact
Issuer symbol
XENE
Transactions as of
03 Jun 2021
Net transactions value
$0
Form type
3
Filing time
03 Jun 2021, 16:35:43 UTC
Next filing
14 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding XENE No securities are beneficially owned. 0 03 Jun 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding XENE Stock Option (Right to Buy) 03 Jun 2021 Common Shares 32 $7.49 Direct F2
holding XENE Stock Option (Right to Buy) 03 Jun 2021 Common Shares 813 $8.40 Direct F3
holding XENE Stock Option (Right to Buy) 03 Jun 2021 Common Shares 2,292 $3.10 Direct F4
holding XENE Stock Option (Right to Buy) 03 Jun 2021 Common Shares 6,511 $4.75 Direct F5
holding XENE Stock Option (Right to Buy) 03 Jun 2021 Common Shares 18,334 $9.44 Direct F6
holding XENE Stock Option (Right to Buy) 03 Jun 2021 Common Shares 22,000 $11.58 Direct F7
holding XENE Stock Option (Right to Buy) 03 Jun 2021 Common Shares 22,000 $20.55 Direct F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Not applicable.
F2 The shares subject to the option fully vested on December 31, 2019.
F3 The shares subject to the option fully vested on December 31, 2020.
F4 Vested 25% on October 23, 2018 and remaining 75% vesting thereafter over the course of the next 3 years, in equal amounts, on the last day of each month.
F5 Vested 25% on January 1, 2019 and remaining 75% vesting thereafter over the course of the next 3 years, in equal amounts, on the last day of each month.
F6 The shares subject to the option vest each monthly anniversary of the September 16, 2019 vesting commencement date over 3 years.
F7 Vested 25% on January 1, 2021 and remaining 75% vesting thereafter over the course of the next 3 years, in equal amounts, on the last day of each month.
F8 Vesting 25% on January 1, 2022 and 75% vesting thereafter over the course of the next 3 years, in equal amounts, on the last day of each month.